Do hypertensive women with coronary artery disease benefit from lowering systolic blood pressure under 130 mmHg? Long-term mortality in the INternational VErapamil SR-trandolapril STudy (INVEST)

3 September 2019 (12:40 - 13:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Ruxandra Sava

Hospital Center of Wallonie Picarde, Tournai (Belgium)

6 More presentations in this session

Presentation thumbnail

2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT

Doctor M. Pareek (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

All-cause mortality and cardiovascular death according to blood pressure thresholds recommended by ACC/AHA

Doctor G. Joseph (Roskilde, DK)

Abstract Slides

Presentation thumbnail

Association of systolic blood pressure and cardiovascular outcomes at different age groups in the healthy general population: a nationwide prospective cohort study

Doctor M. Jung (Seoul, KR)

Abstract Slides

Presentation thumbnail

Restricted mean survival time analysis to assess efficacy and safety of intensive vs standard blood pressure treatment goals as a function of age: insights from the SPRINT trial

Doctor A. Krishnaswami (San Jose, US)

Abstract Slides

Presentation thumbnail

Optimal blood pressure in diabetic hypertensive patients with overt proteinuria

Professor S. Park (Seoul, KR)

Abstract Slides

Access the full session

Session thumbnail

Hypertension: epidemiology, targets and comorbidities

The Event

ESC Congress 2019

3 September 2019 12:40 CET